A Stanford-led team has replaced toxic pre-transplant chemotherapy with a targeted antibody, allowing children with Fanconi anemia to receive stem cell transplants safely. The antibody, briquilimab, removes diseased stem cells without radiation, enabling nearly complete donor cell replacement. The approach also widens donor eligibility and could soon be applied to other bone marrow failure diseases.
source https://www.sciencedaily.com/releases/2025/11/251107010324.htm
'Feathered dragon' has some of the longest tail feathers ever found on a
fossil bird
-
Birds have all kinds of fancy decorations for attracting mates—male
peacocks have a fan of feathers accented with shimmering blue eye-spots,
birds of parad...
4 hours ago
No comments:
Post a Comment